Time-action profile of insulin glargine (HOE901) in Japanese volunteers

被引：0
|
作者：
Rave, K
Heise, T
Heinemann, L
机构：
来源：
DIABETES | 2000年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1524
引用
收藏
页码：A363 / A363
页数：1
相关论文
共 50 条
  • [41] Safety and efficacy of insulin glargine (HOE 901) versus NPH insulin in combination with oral treatment in Type 2 diabetic patients
    Pfeiffer, C
    Winkler, F
    Luger, A
    Pieber, T
    Saudek, F
    Skrha, J
    Hermansen, K
    Lervang, HH
    Nistrup-Holmegaard, S
    Bergkulla, S
    Lembcke, HJ
    Schulze, J
    Petersen, KG
    Haslbeck, M
    Jonker, JJC
    Vaaler, S
    Rolstad, OJ
    Distiller, LA
    Robertson, LI
    Omar, MAK
    Wing, J
    Arner, P
    Arnqvist, H
    Lager, I
    Lennerhagen, P
    Borthwick, LJ
    Hattersley, A
    Owens, DR
    Matthews, DR
    Nattrass, M
    DIABETIC MEDICINE, 2003, 20 (07) : 545 - 551
  • [42] Time-action profile of insulin glulisine (GLU) versus regular human insulin (RHI) and insulin lispro (IL) in obese subjects
    Frick, AD
    Burger, F
    Scholtz, H
    Becker, RHA
    DIABETES, 2004, 53 : A124 - A124
  • [43] Basal insulin glargine (HOE 901)in Type 2 diabetes: A 28-week NPH controlled trial.
    Rosenstack, J
    Schwartz, S
    Clark, C
    Edwards, M
    Donley, D
    DIABETOLOGIA, 1999, 42 : A18 - A18
  • [44] Pharmacokinetics and dynamics of SC injection of the long-acting insulin glargine (HOE 901) in T1DM.
    Lepore, M
    Kurzhals, R
    Pampanelli, S
    Fanelli, CG
    Bolli, GB
    DIABETOLOGIA, 1999, 42 : A233 - A233
  • [45] TIME-ACTION CHARACTERISTICS OF REGULAR AND NPH INSULIN IN INSULIN-TREATED DIABETICS
    ROY, B
    CHOU, MCY
    FIELD, JB
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 50 (03): : 475 - 479
  • [46] Time-action profile of insulin detemir and NPH insulin in patients with type 2 diabetes from different ethnic groups
    Hompesch, M.
    Troupin, B.
    Heise, T.
    Elbroend, B.
    Endahl, L.
    Haahr, H.
    Heinemann, L.
    DIABETES OBESITY & METABOLISM, 2006, 8 (05): : 568 - 573
  • [47] Time-action profiles of insulin detemir in normal and diabetic dogs
    Sako, T.
    Mori, A.
    Lee, P.
    Oda, H.
    Saeki, K.
    Miki, Y.
    Kurishima, M.
    Mimura, K.
    Nozawa, S.
    Mizutani, H.
    Makino, Y.
    Ishioka, K.
    Arai, T.
    RESEARCH IN VETERINARY SCIENCE, 2011, 90 (03) : 396 - 403
  • [48] Time-action profiles of premixed formulations of insulin lispro and NPL-insulin.
    Heise, T
    Weyer, C
    Serwas, A
    Heinrichs, S
    Osinga, J
    Roach, P
    Woodworth, J
    Heinemann, L
    DIABETES, 1997, 46 : 586 - 586
  • [49] Time-action profiles of premixed formulations of insulin lispro and NPL-insulin
    Heise, T
    Weyer, C
    Serwas, A
    Heinrichs, S
    Osinga, J
    Roach, P
    Woodworth, J
    Heinemann, L
    DIABETOLOGIA, 1997, 40 : 1394 - 1394
  • [50] Time-action profiles of novel premixed preparations of insulin lispro and NPL insulin
    Heise, T
    Weyer, C
    Serwas, A
    Heinrichs, S
    Osinga, J
    Roach, P
    Woodworth, J
    Gudat, U
    Heinemann, L
    DIABETES CARE, 1998, 21 (05) : 800 - 803
12345